Versant Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.61K | Sell |
505
-980
| -66% | -$8.94K | ﹤0.01% | 2181 |
|
|
2025
Q1 | $11.8K | Buy |
1,485
+1,249
| +529% | +$9.93K | ﹤0.01% | 1640 |
|
|
2024
Q4 | $1.28K | Sell |
236
-110
| -32% | -$597 | ﹤0.01% | 2145 |
|
|
2024
Q3 | $2.5K | Buy |
346
+259
| +298% | +$1.87K | ﹤0.01% | 1509 |
|
|
2024
Q2 | $945 | Buy |
87
+57
| +190% | +$619 | ﹤0.01% | 1687 |
|
|
2024
Q1 | $562 | Hold |
30
| – | – | ﹤0.01% | 1670 |
|
|
2023
Q4 | $650 | Buy |
30
+22
| +275% | +$477 | ﹤0.01% | 1620 |
|
|
2023
Q3 | $165 | Sell |
8
-7
| -47% | -$144 | ﹤0.01% | 1894 |
|
|
2023
Q2 | $705 | Buy |
+15
| New | +$705 | ﹤0.01% | 1727 |
|